BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Apoptosis, HIV infection, Intestine, Avian flu virus, Aspirin, rs2300478, FOXP1)
Bookmark Forward

QuickView for nisoldipine (compound)


Genetic Markers

Most Correlated Genes

  1. CALM2
  2. SELENOK
  3. SEMA5A
  4. NT5E
  5. COX5A
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. PILON_KLF1_TARGETS_DN
  2. cytosol
  3. response to organic substance
  4. regulation of nitrogen compound metabolic process
  5. DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Liver Pharmacology and Xenobiotic Response Repertoire
  2. Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
  3. B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
  4. Drug target sets for approved compounds
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Effect of nisoldipine and olmesartan on endothelium-dependent vasodilation in essential hypertensive…
  2. Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs.
  3. Simultaneous determination of m-nisoldipine and its three metabolites in rat plasma by liquid chroma…
  4. Effect of m-nisoldipine on the Ca2+/CaM/CaN signal pathway in 5-HT-induced proliferation of rat PASM…
  5. Capillary electrophoretic enantioseparation of m-nisoldipine using two different beta-cyclodextrins.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mg
  2. Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets 40 mg
  3. Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy
  4. Single-Dose Fed Bioequivalence Study of Nisoldipine Extended-Release Tablets (40 mg; Mylan) and Sula…
  5. Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.